Lorcaserin Extended-Release Tablets and Peg Intron RP
Determining the interaction of Lorcaserin Extended-Release Tablets and Peg Intron RP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: peginterferon alfa-2b
Brand name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: PegIntron, Pegintron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-PEG-3350 with Electolytes
- Lorcaserin Extended-Release Tablets-PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride
- Lorcaserin Extended-Release Tablets-PEG-Prep and Bisacodyl
- Lorcaserin Extended-Release Tablets-PEG3350
- Lorcaserin Extended-Release Tablets-Pegademase bovine
- Lorcaserin Extended-Release Tablets-Pegademase Bovine Injection
- Peg Intron RP-Lorcaserin Hydrochloride
- Peg Intron RP-Lorcaserin Tablets
- Peg Intron RP-Lorcet
- Peg Intron RP-Lorcet Plus
- Peg Intron RP-Lorcet Tablets
- Peg Intron RP-Lorlatinib